Poland· PL-100486993
Aquipta
A atogepant product containing atogepantum, registered in Poland by AbbVie Deutschland GmbH & Co. KG. The same ATC class is registered in 16 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Atogepant is registered in 16 of 19 countries.
Countries holding a registration under ATC N02CD07 (atogepant), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 11 of them publish a price we can compare per daily dose
Atogepant · ATC N02CD07
16 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of atogepant costs, country by country.
Normalised to the WHO defined daily dose (60 mg), so markets compare like for like.
- 2 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Atogepant · price per daily dose (60 mg)
USD · FX 28 Sept 2026
- IT Italy$96.51
- CH Switzerland$95.15
The record
At a glance
URPL (Poland)- Active substance
- Atogepantum
- Manufacturer
- AbbVie Deutschland GmbH & Co. KG
- Country
- Poland (PL)
- ATC code
- N02CD07
- ATC class
- Atogepant
- Defined daily dose
- 60 mg, O
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 3
- gtin08054083026121
- gtin08054083034669
- gtin08054083034676
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Atogepant in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaAQUIPTAAbbVie Deutschland GmbH & Co.KG, Ludwigshafen
- SwitzerlandAquipta
- SpainAQUIPTA 60 MG COMPRIMIDOSAbbvie Deutschland Gmbh & Co. Kg
- FinlandAQUIPTAAbbVie Deutschland GmbH&Co.KG
- FranceAQUIPTA 60 mg, compriméABBVIE DEUTSCHLAND (ALLEMAGNE)
- United KingdomAquipta 60mg tabletsAbbVie Ltd
- IrelandAQUIPTA 60 mg tabletsAbbVie Deutschland GmbH & Co. KG
- IcelandAquiptaAbbVie Deutschland GmbH & Co. KG
Authorised across Europe · EMA
The same active substance is authorised in 4 EEA countries. Names it is sold under:
- United Kingdom (Northern Ireland) · Aquipta
- Iceland · Aquipta
- Liechtenstein · Aquipta
- Norway · Aquipta
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/353fd7b0-a6d3-4f1f-a20c-ec0db29b6ddc GET /v1/drugs/353fd7b0-a6d3-4f1f-a20c-ec0db29b6ddc?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tabletki",
"source": "urpl",
"strength": "60 mg",
"packaging": "Rp ¦ EU/1/23/1750/004 ¦ 151062\n98 tabl.\n08054083026121 ¦ Rp ¦ EU/1/23/1750/003 ¦ 151063\n28 tabl.\n08054083034669 ¦ Rp ¦ EU/1/23/1750/006 ¦ 167483\n2 tabl.\n08054083034676 ¦ Rp ¦ EU/1/23/1750/007 ¦ 167484\n7 tabl.",
"substance": "Atogepantum 60 mg",
"common_name": "Atogepantum",
"pl_product_id": "100486993",
"pozwolenie_nr": null,
"auth_procedure": "CEN",
"authorisation_validity": null
}See everything about atogepant.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.